ARGOS THERAPEUTICS

Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company has clinical trial programs in cancer and human immunodeficiency virus. Its products include AGS-0031 for metastatic renal cell carcinoma; AGS-0041 for HIV; CD83 soluble protein for transplant rejection/autoimmune disorders; Anti IFN-alpha monoclonal antibody2 for lupus; and regulatory T cell therapy3 for autoimmune disorders. The company was formerly known as MERIX Bioscience, Inc. Argos Therapeutics was founded in 1997 and is based in Durham, North Carolina.
ARGOS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
1997-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.argostherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
(919) 287-6300
Email Addresses:
[email protected]
Total Funding:
238.93 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro WordPress Yoast WordPress SEO Plugin Yoast Plugins Yoast SEO Premium WordPress 6.4 Mobile Optimized
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Angimmune
Angimmune develops immunotherapies for cancer and autoimmune diseases, focusing on anti-T cell therapy.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aptamer Therapeutics Creative Group
Aptamer Therapeutics Creative Group develops treatments for infectious diseases, autoimmune diseases, and cancer.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
TapImmune
TapImmune develops immunotherapeutics to treat cancers, infectious diseases, autoimmune disorders, and transplant tissue rejection.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Pharmstandard
Pharmstandard investment in Post-IPO Equity - Argos Therapeutics
Inbio Ventures
Inbio Ventures investment in Post-IPO Equity - Argos Therapeutics
Horizon Technology Finance
Horizon Technology Finance investment in Post-IPO Debt - Argos Therapeutics
Morningside Group
Morningside Group investment in Series E - Argos Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series E - Argos Therapeutics
Caisse de Depot et Placement du Quebec
Caisse de Depot et Placement du Quebec investment in Series E - Argos Therapeutics
TVM Capital
TVM Capital investment in Series E - Argos Therapeutics
Pharmstandard International
Pharmstandard International investment in Series E - Argos Therapeutics
Intersouth Partners
Intersouth Partners investment in Series E - Argos Therapeutics
yet2Ventures
yet2Ventures investment in Series E - Argos Therapeutics
Official Site Inspections
http://www.argostherapeutics.com Semrush global rank: 11.52 M Semrush visits lastest month: 156
- Host name: 104.21.80.1
- IP address: 104.21.80.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Argos Therapeutics"
Argos Therapeutics - Crunchbase Company Profile
Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.See details»
Argos Therapeutics 2025 Company Profile: Valuation, โฆ
Information on acquisition, funding, cap tables, investors, and executives for Argos Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Argos Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Aug 14, 2025 Argos Therapeutics is a biotech company that specializes in creating immunotherapy treatments for various diseases, including cancer, infectious diseases, โฆSee details»
Argos Therapeutics (ARGS) Profile - The Globe and Mail
See the company profile for Argos Therapeutics (ARGS) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Argos Therapeutics - Pharmstd Ventures
Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelisโข technology platform. Argos โฆSee details»
Overview, News & Similar companies - ZoomInfo.com
Apr 27, 2018 View Argos Therapeutics (www.argostherapeutics.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well โฆSee details»
Argos Therapeutics - 2025 Company Profile - Tracxn
Jun 23, 2025 Argos Therapeutics is an acquired company based in Durham (United States), founded in 1997. It operates as a RNA-based dendritic cell therapies for cancer and infectious โฆSee details»
Working At Argos Therapeutics: Company Overview and Culture
Mar 14, 2024 Find out what it's like to work at Argos Therapeutics. See what kind of people work at Argos Therapeutics, career paths working at Argos Therapeutics, company culture, salaries, โฆSee details»
Argos Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View Argos Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Company Argos Therapeutics Inc Deutsche Boerse AG
Business description: Argos Therapeutics Inc Argos Therapeutics, Inc. (Argos) is an immuno-oncology company. The Company is focused on the development and commercialization of โฆSee details»
Argos Therapeutics, Inc. (NASDAQ: ARGS) Information
Argos Therapeutics, Inc. (NASDAQ: ARGS) is a Biotechnology, Manufacturing General, and Dendritic cells company_reader located in Durham, North Carolina with $1 million in revenue โฆSee details»
Argos Therapeutics - Ownership and Business Overview | Mergr
Feb 13, 2019 Where is Argos Therapeutics headquartered? Argos Therapeutics is headquartered in Durham, North Carolina. What is Argos Therapeuticsโ revenue? Argos โฆSee details»
Argos Therapeutics, Inc. (NASDAQ: ARGS) Company Overview, โฆ
Argostherapeutics hired Abbey as president and chief executive officer on Jan 1st '02. Mr. Abbey joined Argos Therapeutics in 2002, leading the company's business development efforts until โฆSee details»
Argos Therapeutics - VentureRadar
"Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and โฆSee details»
Argos Therapeutics - Financial Details - Crunchbase
Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.See details»
Company Argos Therapeutics Inc OTC Bulletin Board
Business description: Argos Therapeutics Inc Argos Therapeutics, Inc. (Argos) is an immuno-oncology company. The Company is focused on the development and commercialization of โฆSee details»
Argos Therapeutics - Leadership Team | The Org
The Leadership Team at Argos Therapeutics is responsible for setting the strategic direction and overseeing the execution of the companyโs mission to develop innovative immunotherapy โฆSee details»
Argos Therapeutics (Merix Biosciences) Company Overview, โฆ
Learn more about Argos Therapeutics (Merix Biosciences)'s company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Company Argos Therapeutics, Inc. - MarketScreener.com
Business description: Argos Therapeutics, Inc. Argos Therapeutics, Inc. (Argos) is an immuno-oncology company. The Company is focused on the development and commercialization of โฆSee details»
FOR IMMEDIATE RELEASE - argostherapeutics.com
About Argos Therapeutics, Inc. Argos is an immunotherapy company developing new treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The Company โฆSee details»